Lung Ultrasound in Comparison With C.T in Covid-19

December 14, 2021 updated by: Esraa Mohamed Amin, Sohag University

Can Lung Ultrasound Play a Competitive Role With Computed Tomography in Diagnosis and Follow up of Covid-19 Patients?

investigate the diagnostic ability of thoracic ultrasound in suspicious COVID-19 infection and/or COVID-19 pneumonia. Also, to compare its findings to CT and follow up these findings.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

ultrasound and C.T will be assessed in acute presentation of Covid 19 patients and then those patients will be reassessed again after 1 month by lung ultrasound and C.T and if ultrasound will show the same efficacy of diagnosis or not

Study Type

Observational

Enrollment (Anticipated)

200

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 95 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

covid 19 patients in acute phase and follow up after 1 and 2 months

Description

Inclusion Criteria:

  • all cases of covid 19 patients

Exclusion Criteria:

  • all other causes of consolidation ,ground glass fibrosis or collapse findings of C.T and ultrasound

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
covid 19 in acute phase
lung ultrasound in comparison to C.T
covid 19 follow up
lung ultrasound in comparison to C.T

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diagnostic ability of thoracic ultrasound for diagnosis and follow up of covid19 patients
Time Frame: after 1 month of acute presentation
compare lung ultrasound with C.T finding of covid 19 patients
after 1 month of acute presentation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2022

Primary Completion (Anticipated)

January 1, 2024

Study Completion (Anticipated)

December 30, 2024

Study Registration Dates

First Submitted

December 12, 2021

First Submitted That Met QC Criteria

December 14, 2021

First Posted (Actual)

December 15, 2021

Study Record Updates

Last Update Posted (Actual)

December 15, 2021

Last Update Submitted That Met QC Criteria

December 14, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on ultrasound and C.T

Subscribe